Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma

Autor: Surena F. Matin, Andrew C. Thorpe, Wassim Kassouf, Colin P.N. Dinney, Andrew J. Stephenson, Trinity J. Bivalacqua, Yair Lotan, Firas G. Petros, Marc A. Dall'Era, Homayoun Zargar, Todd M. Morgan, Peter C. Black, Jonathan L. Wright, Shahrokh F. Shariat, Philippe E. Spiess, Srikala S. Sridhar, John S. McGrath, Daniel A. Barocas, David D'Andrea, Michael S. Cookson, Jeffrey M. Holzbeierlein, Bas W.G. van Rhijn, Scott North, Siamak Daneshmand
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Bju International
ISSN: 1464-410X
1464-4096
Popis: OBJECTIVE To assess the differential response to neoadjuvant chemotherapy (NAC) in patients with urothelial carcinoma of the bladder (UCB) compared to upper tract urothelial carcioma (UTUC) treated with radical surgery. PATIENTS AND METHODS Data from 1299 patients with UCB and 276 with UTUC were obtained from multicentric collaborations. The association of disease location (UCB vs UTUC) with pathological complete response (pCR, defined as a post-treatment pathological stage ypT0N0) and pathological objective response (pOR, defined as ypT0-Ta-Tis-T1N0) after NAC was evaluated using logistic regression analyses. The association with overall (OS) and cancer-specific survival (CSS) was evaluated using Cox regression analyses. RESULTS A pCR was found in 250 (19.2%) patients with UCB and in 23 (8.3%) with UTUC (P
Databáze: OpenAIRE